OCGN
Price
$1.33
Change
+$0.01 (+0.76%)
Updated
May 3, 6:59 PM EST
90 days until earnings call
PTIX
Price
$1.29
Change
-$0.01 (-0.77%)
Updated
May 3, 6:59 PM EST
Ad is loading...

Compare trend and price OCGN vs PTIX

Header iconOCGN vs PTIX Comparison
Open Charts OCGN vs PTIXBanner chart's image
Ocugen
Price$1.33
Change+$0.01 (+0.76%)
Volume$3.19M
CapitalizationN/A
Protagenic Therapeutics
Price$1.29
Change-$0.01 (-0.77%)
Volume$836
CapitalizationN/A
View a ticker or compare two or three
OCGN vs PTIX Comparison Chart

Loading...

OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
OCGN vs. PTIX commentary
May 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCGN is a Hold and PTIX is a Hold.

COMPARISON
Comparison
May 04, 2024
Stock price -- (OCGN: $1.33 vs. PTIX: $1.28)
Brand notoriety: OCGN and PTIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCGN: 52% vs. PTIX: 14%
Market capitalization -- OCGN: $342.25M vs. PTIX: $5.68M
OCGN [@Biotechnology] is valued at $342.25M. PTIX’s [@Biotechnology] market capitalization is $5.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCGN’s FA Score shows that 0 FA rating(s) are green whilePTIX’s FA Score has 1 green FA rating(s).

  • OCGN’s FA Score: 0 green, 5 red.
  • PTIX’s FA Score: 1 green, 4 red.
According to our system of comparison, PTIX is a better buy in the long-term than OCGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCGN’s TA Score shows that 4 TA indicator(s) are bullish.

  • OCGN’s TA Score: 4 bullish, 5 bearish.

Price Growth

OCGN (@Biotechnology) experienced а +3.91% price change this week, while PTIX (@Biotechnology) price change was -7.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was +1240.85%.

Reported Earning Dates

OCGN is expected to report earnings on Aug 02, 2024.

PTIX is expected to report earnings on May 31, 2023.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for OCGN with price predictions.
OPEN
A.I.dvisor published
a Summary for PTIX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
OCGN($342M) has a higher market cap than PTIX($5.68M). OCGN YTD gains are higher at: 129.565 vs. PTIX (38.889).
OCGNPTIXOCGN / PTIX
Capitalization342M5.68M6,024%
EBITDAN/AN/A-
Gain YTD129.56538.889333%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
OCGN vs PTIX: Fundamental Ratings
OCGN
PTIX
OUTLOOK RATING
1..100
2178
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
3450
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTIX's Valuation (25) in the null industry is somewhat better than the same rating for OCGN (66). This means that PTIX’s stock grew somewhat faster than OCGN’s over the last 12 months.

PTIX's Profit vs Risk Rating (100) in the null industry is in the same range as OCGN (100). This means that PTIX’s stock grew similarly to OCGN’s over the last 12 months.

PTIX's SMR Rating (97) in the null industry is in the same range as OCGN (98). This means that PTIX’s stock grew similarly to OCGN’s over the last 12 months.

OCGN's Price Growth Rating (34) in the null industry is in the same range as PTIX (50). This means that OCGN’s stock grew similarly to PTIX’s over the last 12 months.

OCGN's P/E Growth Rating (100) in the null industry is in the same range as PTIX (100). This means that OCGN’s stock grew similarly to PTIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OCGN
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSVRX42.080.67
+1.62%
Columbia Small Cap Value I R
VSQAX16.310.09
+0.55%
Invesco MSCI World SRI Index A
SWDSX14.470.05
+0.35%
Schwab Dividend Equity
TRLIX21.190.06
+0.28%
Nuveen Large Cap Value Instl
GQHIX12.290.03
+0.24%
GQG Partners US Quality Dividend Inc Ins

OCGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCGN has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if OCGN jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCGN
1D Price
Change %
OCGN100%
-5.04%
MDGL - OCGN
51%
Loosely correlated
+2.59%
ARRY - OCGN
47%
Loosely correlated
+4.82%
AXON - OCGN
46%
Loosely correlated
+1.66%
XNCR - OCGN
36%
Loosely correlated
-1.25%
PHAT - OCGN
35%
Loosely correlated
+5.40%
More

PTIX and

Correlation & Price change

A.I.dvisor tells us that PTIX and SQZB have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTIX and SQZB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTIX
1D Price
Change %
PTIX100%
+5.77%
SQZB - PTIX
26%
Poorly correlated
N/A
PIRS - PTIX
26%
Poorly correlated
-3.77%
ATXI - PTIX
25%
Poorly correlated
+0.21%
OCGN - PTIX
25%
Poorly correlated
-5.04%
AKRO - PTIX
25%
Poorly correlated
-1.84%
More